Ulisse Biomed S.p.A. (BIT:UBM)
Italy flag Italy · Delayed Price · Currency is EUR
0.7880
+0.0260 (3.41%)
Apr 2, 2025, 2:10 PM CET

Ulisse Biomed Revenue

Ulisse Biomed had revenue of 370.86K EUR in the half year ending June 30, 2024, with 482.47% growth. This brings the company's revenue in the last twelve months to 420.92K, up 363.03% year-over-year. In the year 2023, Ulisse Biomed had annual revenue of 66.21K, down -52.17%.

Revenue (ttm)
420.92K
Revenue Growth
+363.03%
P/S Ratio
39.47
Revenue / Employee
52.62K
Employees
10
Market Cap
18.66M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202366.21K-72.23K-52.17%
Dec 31, 2022138.44K-142.00K-50.64%
Dec 31, 2021280.44K-325.06K-53.68%
Dec 31, 2020605.50K594.63K5,469.84%
Dec 31, 201910.87K10.80K14,203.95%
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Recordati Industria Chimica e Farmaceutica 2.34B
DiaSorin 1.19B
Amplifon 2.41B
Philogen 3.92M
EL.En. 565.85M
Pharmanutra 116.15M
Garofalo Health Care 470.71M
Safilo Group 993.22M
Revenue Rankings